test

Manish Mital

@Braidwell Lp

Latest period2024 - Q3ReportedManaged Assets$3.528BTotal holdings81
Assets growth rate10.68%Assets growth rate (2-Q avg)6.71%Continuous growth in asset value3 quarters

Portfolio positions

This chart displays the top 10 holdings in Braidwell Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 81 positions.

Assets under management

The assets under management (AUM) of Braidwell Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.528B in assets, with a quarterly growth rate of 10.68% and a 2-quarter average growth rate of 6.71%. The portfolio is managed by Manish Mital, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
XENEXenon Pharmaceuticals Inc
Recent Activity
Increased 5.73%
3.03%
$106.585M
2.707M shares@ $39.37 avg price
NBIXNeurocrine Biosciences Inc
Recent Activity
Increased 20.91%
3%
$105.734M
917,674 shares@ $115.22 avg price
APLSApellis Pharmaceuticals Inc
Recent Activity
Increased 410.82%
2.56%
$90.13M
3.125M shares@ $28.85 avg price
4633⤦Ironwood Pharmaceuticals Inc
Recent Activity
Increased 3.35%
2.34%
$82.465M
92.74M shares@ $0.89 avg price
2521⤦Dexcom Inc
Recent Activity
Increased 12.1%
2.34%
$82.271M
92.7M shares@ $0.89 avg price
ALGNAlign Technology Inc
Recent Activity
Increased 13.26%
2.25%
$79.266M
311,679 shares@ $254.32 avg price
GHGuardant Health Inc
Recent Activity
Increased 19.03%
2.18%
$76.668M
3.342M shares@ $22.95 avg price
VKTXViking Therapeutics Inc
Recent Activity
Increased 4.53%
2.08%
$73.248M
1.157M shares@ $63.32 avg price
KNSAKiniksa Pharmaceuticals Intl
Recent Activity
Increased 40.63%
2.06%
$72.334M
2.895M shares@ $25.0 avg price
PENPenumbra Inc
Recent Activity
Increased 70.01%
2%
$70.229M
361,428 shares@ $194.32 avg price